|Day Low/High||13.95 / 14.30|
|52 Wk Low/High||5.90 / 13.18|
Anika focuses on pain management, tissue regeneration and wound healing.
Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.
Investors in Cytokinetics Inc saw new options begin trading this week, for the June 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CYTK options chain for the new June 16th contracts and identified one put and one call contract of particular interest.
Arena Pharmaceuticals, Rigel Pharmaceuticals and Cytokinetics were among the biotech stock movers in premarket trading on Tuesday.
Investors in Cytokinetics Inc saw new options become available this week, for the November 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 225 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Research Aimed at Accelerating Conduct of Clinical Trials
Next-Generation Fast Skeletal Troponin Activator Improves Muscle Function in Mouse Models of Spinal Muscular Atrophy
Let's take a look at several stocks that are experiencing unusual volume activity.
Here's a technical look at how to play a number of stocks trending higher with strong volume.
Sucampo Pharmaceuticals, Intellia Therapeutics and Cytokinetics were among the biotech stock movers in premarket trading on Wednesday.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
In addition to Sage Therapeutics, also moving biotech Friday: Novavax, Cytokinetics and Acadia Pharmaceuticals.
Shares of late-stage biopharma Cytokinetics increased following positive comments from an Needham analyst.